Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeting JAK/STAT Signaling Antagonizes Resistance to Oncolytic Reovirus Therapy Driven by Prior Infection with HTLV-1 in Models of T-Cell Lymphoma

Viruses(2021)10.3390/v13071406Source: DataRank Database

Targeting JAK/STAT Signaling Antagonizes Resistance to Oncolytic Reovirus Therapy Driven by Prior Infection with HTLV-1 in Models of T-Cell Lymphoma is a research paper published in Viruses (2021). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.29)OA: goldTopics (71)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Claudia M. Espitia ORCID,Daniel O. Persky ORCID,Jennifer S. Carew ORCID,Steffan T. Nawrocki ORCID,Shariful Islam ORCID

Live enrichment

PubMed:34372612 PMC:PMC8310324 OpenAlex:https://openalex.org/W3186432195

National Institutes of Health

Grant: R01CA190789

National Institutes of Health

Grant: R01CA172443

National Institutes of Health

Grant: P30CA023074

NCI NIH HHS

Grant: R41 CA271967

National Institutes of Health

Grant: 5R01CA172443-04

Targeting NEDD8-Mediated Protein Turnover in AML

National Institutes of Health

Grant: 2P30CA023074-41

University of Arizona Cancer Center - Cancer Center Support Grant

National Institutes of Health

Grant: 5R01CA190789-06

Endoplasmic reticulum stress and oncoviral therapy

FWCI

0.29

Citation Percentile

0.5%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/1999-4915/13/7/1406/pdf?version=1626767707

publisherhttps://www.mdpi.com/1999-4915/13/7/1406/pdf?version=1626767707

publisherhttps://www.mdpi.com/1999-4915/13/7/1406/pdf

journalhttps://doi.org/10.3390/v13071406

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34372612

Fields of Study

T-cell and Retrovirus StudiesAnimal Disease Management and EpidemiologyVector-Borne Animal Diseases0301 basic medicine03 medical and health sciences0303 health sciencesCell Line, TumorGene Expression ProfilingHuman T-lymphotropic virus 1HumansJanus KinasesLeukemia-Lymphoma, Adult T-CellNitrilesOncolytic VirusesPhosphorylationPyrazolesPyrimidinesReoviridaeSTAT5 Transcription FactorSignal Transduction

MeSH Terms

HumansNitrilesPhosphorylationPyrazolesPyrimidinesReoviridaeHuman T-lymphotropic virus 1Signal TransductionLeukemia-Lymphoma, Adult T-CellGene Expression ProfilingCell Line, TumorOncolytic VirusesSTAT5 Transcription FactorJanus Kinases

Keywords

Oncolytic virusVirologySTAT5BiologyHuman T-lymphotropic virus 1LymphomaSTAT proteinTropical spastic paraparesisRetrovirusCancer researchJAK-STAT signaling pathwaySTAT3VirusImmunologyT-cell leukemiaSignal transductionTyrosine kinasereovirusHtlv-1T-cell LymphomaReolysinPelareorepReoviridaeMicrobiologyArticleCell Line, TumorNitrilesSTAT5 Transcription FactorHumansLeukemia-Lymphoma, Adult T-CellPhosphorylationJanus KinasesGene Expression ProfilingQR1-502Oncolytic VirusesPyrimidinesPyrazoles

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being